Access to Medicine Index · AMR Benchmark
Your access to medicine record, in your own evidence.
The Access to Medicine Foundation chooses which companies its Index and its antimicrobial resistance (AMR) Benchmark assess. If yours is one, EA drafts the Foundation’s survey from last cycle’s submission, your access plans and registration records, asks R&D, market access and manufacturing for what only they hold, and brings it to your Head of Sustainability to approve.
Try EA free. No card needed.
Organisations that run work on EA
The work
Two years apart, and never quite the same survey.
The methodology moves between cycles
The 2026 Index cut its indicators from 32 to 29, widened the diseases it covers and redefined inclusive business models, so last cycle’s answers no longer line up one for one.
Every function holds a piece
Access plans sit with the portfolio team, registrations and prices with market access, discharge audits with manufacturing and licences with legal, across 113 countries.
The people who answered last time have moved
Two years is long enough for the colleague who wrote last cycle’s patient reach answer to have changed roles, taking the reasoning with them.
The Foundation reads your public record either way. The survey is where your own evidence sits beside it, each answer with the team that stands behind it.
The 2026 methodology
Over half the score is evidence held market by market.
The Foundation weights the 2026 Index across three technical areas, covering 113 low- and middle-income countries and 84 diseases, conditions and pathogens. The heaviest draws on the evidence spread furthest across your company, and that is where EA’s asks go.
- 55 per centProduct Delivery, answered from the registrations, prices, licences and supply that market access, legal and manufacturing hold in each country
- 30 per centResearch and Development, answered from the pipeline and the access plan your portfolio team holds for each candidate
- 15 per centGovernance of Access, answered from the board oversight, incentives, compliance record and patient reach measurement your access and compliance teams keep
Access to Medicine Foundation, 2026 Index methodology.
What EA does
From last cycle’s answers to this cycle’s indicators.
One company’s Index survey in EA, from the new methodology to the submission your team makes. An AMR Benchmark survey runs the same way across its 16 indicators, with manufacturing’s discharge audits among the asks.
01 / 04
- EA
Reads the 2026 methodology beside your last submission and report card, carries each answer to the indicator that now asks it, and marks what changed: answers given to the three retired indicators, the patient reach reporting the methodology now asks more of, and the diseases added to the scope. Knowledge Library
Your teamThe Global Health Lead decides what carries over and assigns each technical area to its owner.
- EA
Drafts each answer from your access strategy, portfolio committee minutes, pricing policies and licence agreements, with the source beside it, and puts your own record beside each figure the Foundation drew from public sources. Knowledge Library
Your teamYour team confirms or corrects the Foundation’s figures, and decides which programmes meet its definitions.
- EA
Sends one ask per owner, such as registrations by country to the Head of Market Access and discharge audits to the Head of Environment, Health and Safety, follows up, and files each reply against its indicator. EA Agent
Your teamThe Global Health Lead sees what is still due across all three technical areas.
- EA
Brings the survey together with the source and reviewer beside each answer, and exports it in the Foundation’s order. Approvals
Your teamThe Head of Sustainability approves; your team submits, and answers the Foundation’s verification questions.
See a late-stage candidate’s access plan become the answer the Foundation reads.
Book a demoNext cycle
The next survey starts where this one was approved.
A new methodology
When the Foundation publishes the next methodology, EA sets this cycle’s answers against it, so your team reads what changed rather than the whole survey.
Your report card’s findings
The actions the report card points to are kept beside the answers they concern, so the next cycle can show what was done.
The same evidence for other askers
When investors or a rating agency ask about access to medicine, EA drafts the answer from this cycle’s survey, each figure with its source.
- Answer
- Access plans for late-stage candidates
- Source
- Portfolio committee minutes, March 2026
- Approved by
- Head of Sustainability
- Used in
- Next cycle’s starting draft
EA’s own security
The pipeline stays with the people you choose.
The survey draws on candidates, licence terms and prices by country that you don’t publish.
- Hosted your way
EA’s cloud in a region you choose, hybrid options or on-premises. Data never used to train the models EA runs on.
- Access
Single sign-on, which you can enforce, and an access list for each workspace.
- Support access
EA staff see your data only in a time-limited window you open.
- Testing
An independent firm runs a penetration test on EA every year.
- Security contact
EA’s security team is at security@eaglobal.ai.
See how the portfolio team answers its own indicators while prices by country stay with market access.
Book a demoFAQ
Questions from companies in the Foundation’s scope.
The Foundation decides who is in scope: 20 large research-based companies for the Index, and for the 2026 AMR Benchmark 25 companies, from large research-based firms to generic manufacturers and smaller companies. A company it names is assessed from public data even without a survey response, so the survey is where your own records are added. EA is for the companies preparing that response.
The Foundation does. It cross-checks each answer against public sources, has key sections reviewed by independent experts, including its Expert Review Committee, and publishes the Index ranking with a report card for each company; the AMR Benchmark scores each company without ranking them. Your team submits the survey and answers the Foundation’s clarification questions.
Whether a programme meets the Foundation’s definition, such as an inclusive business model, is your team’s call. EA drafts each answer from the record behind it, and if the draft describes a pricing scheme with no patient reach data on file, it marks the answer “Needs evidence” and asks the Head of Market Access.
Only the colleagues you add. The Head of Legal can answer the licensing indicators without opening the portfolio committee minutes, and the Head of Environment, Health and Safety sees only the manufacturing indicators.
With last cycle’s submission, the Foundation’s clarification questions, your report card and the current methodology, as they are. Our Customer Success team helps with exports from other platforms. Plans differ by the number of autofills, the workspaces you need and the size of your knowledge library; see the pricing page.
Your next access survey, without rebuilding two years of evidence.
One indicator, from last cycle to your Head of Sustainability.
Where the same access record is read.
Related solutions
GRIAccess to medicines sits among a pharmaceutical company’s material topics, with its own disclosures in the annual report.ESG and sustainability
- ESG ratingsThe investors who attend the Index launch also read the rating agencies’ research on access.ESG and sustainability
By industry
Healthcare and life sciencesQuality, regulatory and access teams hold the files every assessor of a pharmaceutical company asks for.
Public sector and defenceSelection questionnaires, declarations and the carbon reduction plan, signed off by the right director.
Banking and building societiesThe operational resilience self-assessment and supplier reviews, attested by name.
Asset and investment managementInvestors’ DDQs, operational due diligence and the Principles for Responsible Investment report.
InsuranceBroker questionnaires, Lloyd’s confirmations and the own risk and solvency assessment.
Construction and infrastructureScheme renewals, prequalification and ISO evidence, including international engineering, procurement and construction projects.
Manufacturing and consumer goodsCustomers’ supplier questionnaires, Sedex and the conflict minerals template.
Energy and utilitiesThe CSRD statement, CDP, regulator returns and the network and information security self-assessment.
SoftwareCustomers’ security questionnaires and your own SOC 2 evidence.
Legal firmsPanel questionnaires, the professional indemnity renewal and Lexcel evidence, signed off by a partner.
Accounting firmsClients’ security questionnaires and the firm’s anti-money laundering return.
ConsultingClients’ vendor due diligence, framework tenders and the certificates behind them.

